Literature DB >> 15888536

Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients.

E J Kim1, S S Cho, Y Jeong, K C Park, S J Kang, E Kang, S E Kim, K H Lee, D L Na.   

Abstract

The aims of this cross-sectional study were (i) to compare the overall glucose metabolism between early onset and late onset Alzheimer's disease in a large sample of patients; and (ii) to investigate the pattern of glucose metabolism as a function of dementia severity in early onset versus late onset Alzheimer's disease, using a statistical parametric mapping (SPM) analysis. Subjects consisted of four groups: 74 patients with early onset Alzheimer's disease, 46 patients with late onset of the disease, and two control groups age matched to each patient group. All the subjects underwent 2-[(18)F]fluoro-2-deoxy-d-glucose (FDG)-PET under the same scanning conditions. Severity of dementia was rated with the Clincial Dementia Rating (CDR). Voxel-based SPM99 was used for statistical analyses. Overall glucose hypometabolism of early onset Alzheimer's disease patients was much greater in magnitude and extent than that of late onset patients, though both groups were similar in dementia severity: the early onset group showed more severe hypometabolism in parietal, frontal and subcortical (basal ganglia and thalamus) areas. When the decline of glucose metabolism was compared as a function of CDR stage, the slope was steeper in early onset than in late onset Alzheimer's disease. The rapid decline occurred at CDR 0.5-1 in the early onset group, whereas similar changes occurred at CDR 2-3 in the late onset group. The greater hypometabolism in early onset than in late onset patients is required to reach the same severity of dementia, probably reflecting greater functional reserve in younger than in older subjects. Alternatively, the metabolic decline curve suggests that the early onset patients may take a more rapid course in the reduction of glucose metabolism than the late onset patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888536     DOI: 10.1093/brain/awh539

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  73 in total

1.  Parietal variant Alzheimer's disease presenting with dyscalculia.

Authors:  Young Ho Park; Jae-Won Jang; Min Jae Baek; Jung E Kim; SangYun Kim
Journal:  Neurol Sci       Date:  2012-06-19       Impact factor: 3.307

2.  Effects of age on the glucose metabolic changes in mild cognitive impairment.

Authors:  Kejal Kantarci; M L Senjem; V J Lowe; H J Wiste; S D Weigand; B J Kemp; A R Frank; M M Shiung; B F Boeve; D S Knopman; R C Petersen; C R Jack
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

Review 3.  Amyloid positron emission tomography and cognitive reserve.

Authors:  Matteo Bauckneht; Agnese Picco; Flavio Nobili; Silvia Morbelli
Journal:  World J Radiol       Date:  2015-12-28

4.  Functional connectivity changes differ in early and late-onset Alzheimer's disease.

Authors:  Natalina Gour; Olivier Felician; Mira Didic; Lejla Koric; Claude Gueriot; Valérie Chanoine; Sylviane Confort-Gouny; Maxime Guye; Mathieu Ceccaldi; Jean Philippe Ranjeva
Journal:  Hum Brain Mapp       Date:  2013-10-05       Impact factor: 5.038

Review 5.  Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging.

Authors:  Lisa Mosconi; Valentina Berti; Lidia Glodzik; Alberto Pupi; Susan De Santi; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Differentiated clinical presentation of early and late-onset Alzheimer's disease: is 65 years of age providing a reliable threshold?

Authors:  Antonio Palasí; Belén Gutiérrez-Iglesias; Montse Alegret; Francesc Pujadas; Mikel Olabarrieta; Diana Liébana; Manolo Quintana; José Álvarez-Sabín; Mercè Boada
Journal:  J Neurol       Date:  2015-03-21       Impact factor: 4.849

7.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Authors:  Gil D Rabinovici; Ansgar J Furst; Adi Alkalay; Caroline A Racine; James P O'Neil; Mustafa Janabi; Suzanne L Baker; Neha Agarwal; Stephen J Bonasera; Elizabeth C Mormino; Michael W Weiner; Maria L Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust
Journal:  Brain       Date:  2010-01-15       Impact factor: 13.501

8.  Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI).

Authors:  C Haense; K Herholz; W J Jagust; W D Heiss
Journal:  Dement Geriatr Cogn Disord       Date:  2009-09-25       Impact factor: 2.959

9.  White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI.

Authors:  Yu Zhang; Norbert Schuff; An-Tao Du; Howard J Rosen; Joel H Kramer; Maria Luisa Gorno-Tempini; Bruce L Miller; Michael W Weiner
Journal:  Brain       Date:  2009-05-12       Impact factor: 13.501

10.  Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.

Authors:  Rachel Mistur; Lisa Mosconi; Susan De Santi; Marla Guzman; Yi Li; Wai Tsui; Mony J de Leon
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.